Parkinsonian micrographia reversed by treatment with weak electromagnetic fields

References

• Aldegunde M., Miquez I., Veira J. Effects of pinealectomy on regional brain serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
   PubMed Web of Science ®Google Scholar
• Anderson L. E. Interaction of electric and magnetic fields with neural and neuroendocrine systems. Extremely low frequency electromagnetic fields: the question of cancer, B. W. Wilson, R. G. Stevens, L. E. Anderson. Battelle Press, Columbus, OH 1990
   Google Scholar
• Anton‐Tay F. Melatonin: effects on brain function. Advances in Biochemical Psychopharmacology 1974; 11: 315–324
   PubMedGoogle Scholar
• Anton‐Tay F., Diaz J. L., Femandez‐Guardiola A. On the effects of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
   Web of Science ®Google Scholar
• Bawin S. M., Adey W. R. Sensitivity of calcium binding in cerebral tissue to weak environmental electrical fields oscillating at low frequency. Proceedings of the National Academy of Sciences USA 1976; 73: 1999–2003
   PubMed Web of Science ®Google Scholar
• Bawin S. M., Gavalas‐Medici R. J., Adey W. R. Effects of modulated very high frequency fields on specific brain rhythms in cats. Brain Research 1973; 58: 365–384
   PubMed Web of Science ®Google Scholar
• Bell G., Marino A., Chesson A., Struve F. Electrical states in the rabbit brain can be altered by light and electromagnetic fields. Brain Research 1992; 570: 307–315
   PubMed Web of Science ®Google Scholar
• Bernheimer H., Birkmayer W., Homykiewicz O. Verteilung des 5‐hydroxytryptamins (Serotonin) in Gehim des Menschen und sein Verhalten bein Patienten mit Parkinson Syndrome. Klinische Wochenschrift 1961; 39: 1056–1059
   PubMedGoogle Scholar
• Blackman C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss, New York 1988
   Google Scholar
• Blackman C. F., Shawnee B. G., Kinney L. S., Joines W. T., House D. E. Effects of ELF fields on calcium‐ion efflux from brain tissue in vitro. Radiation Research 1982; 92: 510–520
   PubMed Web of Science ®Google Scholar
• Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the mid‐brain can regulate dopamine function both behaviourally and biochemically. The pineal gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Pergamon Press, Oxford 1985; 327–332
   Google Scholar
• Brown G., Grota L., Bubenik G., Niles L., Tsui H. Physiologic regulation of melatonin. Melatonin, current status and perspectives, N. Birau, W. Schloot, 1981; 95–112, Advances in Biosciences, 29
   Google Scholar
• Bubenik G. A., Brown G. M., Grota J. L. Differential localization of N‐acetyled indolalkylamines in CNS and the Harderian gland using immunohistology. Brain Research 1976; 118: 417–427
   PubMed Web of Science ®Google Scholar
• Datta P. C., King M. G. Melatonin: effects on brain and behavior. Neuroscience, & Biobehavioral Reviews 1980; 4: 451–458
   PubMed Web of Science ®Google Scholar
• Davidson D. L. W., Yates C. M., Mawdsley C., Pullar I. A., Wilson H. CSF studies on the relationship between dopamine and 5‐hydroxytryptamine in parkinsonism and other movement disorders. Journal of Neurology Neurosurgery and Psychiatry 1977; 40: 1136–1141
   PubMed Web of Science ®Google Scholar
• Demaine C., Semm P. Magnetic fields abolish nychthemeral rhythmicity of responses of Purkinje cells to the pineal hormone melatonin in the pigeon's cerebellum. Neuroscience Letters 1986; 72: 158–162
   PubMed Web of Science ®Google Scholar
• Dray A. Serotonin in the basal ganglia: functions and interactions with other neuronal pathways. Journal of Physiology (Paris) 1981; 77: 393–403
   PubMedGoogle Scholar
• Dubocovich M. L. Melatonin is a potent modulator of dopamine release in the retina. Nature 1983; 306: 782–784
   PubMed Web of Science ®Google Scholar
• Dugovic C., Leysen J. E., Wauquier A. melatonin modulates the sensitivity of 5‐hydroxytryptamine‐2 receptor‐mediated sleep‐wakefulness regulation in the rat. Neuroscience Letters 1989; 104: 320–325
   PubMed Web of Science ®Google Scholar
• Eliasberg W. G. Pen, paper and parkinsonism. Geriatrics 1959; 14: 705–708
   PubMedGoogle Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal gland: anatomy, physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Fischer P. A., Baas H., Hefner R. Treatment of parkinsonian tremor with clozapine. Journal of Neural Transmission 1990; 2: 233–238
   Google Scholar
• Gaffori O., Van Ree J. M. Serotonin and antidepressant drugs antagonize melatonin‐induced behavioural changes after injection into the nucleus accumbens of rats. Neuropharmacology 1985; 24: 237–244
   PubMed Web of Science ®Google Scholar
• Gershanik O. S., Heikkila R. E., Duvoisin R. C. The role of serotonin neurons in the action of L‐dopa in an animal model of Parkinsonism. Neurology 1979; 29: 553
   Web of Science ®Google Scholar
• Golus P., King M. The effects of melatonin in open field behavior. Pharmacology, Biochemistry and Behavior 1981; 15: 883–885
   PubMed Web of Science ®Google Scholar
• Jaffe R. A., Laszewski B. L., Carr D. B., Phillips R. D. Chronic exposure to a 60‐Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioelectromagnetics; 1980; 1: 131–147
   PubMedGoogle Scholar
• Klawans H. L., Goetz C. G., Bergen D. Levodopa‐induced myoclonus. Archives of Neurology 1975; 32: 331–334
   Google Scholar
• Knopp W. Explorations in the assessment and meaning of the subclinical extrapyramidal effect of neuroleptic drugs. Pharmakopsychiatrie 1968; 1: 54–61
   Google Scholar
• Koller W. C. Classification of parkinsonism. Handbook of parkinson's disease, W. C. Roller. Marcel Dekker, New York 1987; 51–80
   Google Scholar
• Kovacs G. L., Gayari I., Telegdy G., Lissak K. Effect of melatonin and pinealectomy on avoidance and exploratory activity in the rat. Physiology, & Behavior 1974; 13: 349–355
   PubMed Web of Science ®Google Scholar
• Laudon M., Zisapel N. Impact of circulating estradiol on melatonin binding sites in discrete areas of the female rat brain. Brain Research 1987; 402: 146–150
   PubMed Web of Science ®Google Scholar
• Laudon M., Nir I., Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577–583
   PubMed Web of Science ®Google Scholar
• LeWitt P. Micrographia as a focal sign of neurological disease. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 1152–1153
   PubMed Web of Science ®Google Scholar
• Lezak M. D. Neuropsychological assessmentsecond Edition. Oxford University Press, New York 1983; 404, 406, & 452
   Google Scholar
• Lloyd O. L. Inhibition of median raphe neurone metabolism by cerebrospinal fluid (CSF) containing 5‐hydroxytryptamine and melatonin. Biochemical Pharmacology 1974; 23: 1913–1915
   PubMed Web of Science ®Google Scholar
• Lynch H. J., Wang P., Wurtman R. J. Increase in rat pineal melatonin content following L‐dopa administration. Life Sciences 1973; 12: 145–151
   Web of Science ®Google Scholar
• Mc Cance‐Katz E. F., Marek K. L., Price L. H. Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology 1992; 42: 1813–1814
   PubMedGoogle Scholar
• Meerwaldt J. D. Treatment of hypokinetic rigid syndrome with fluvoxamine maleate. Lancet 1986; 2: 977–978
   Google Scholar
• Miledi R. Transmitter release induced by injection of calcium ions into nerve terminals. Proceedings of the Royal Society of Biological Sciences 1973; 183: 421–428
   PubMed Web of Science ®Google Scholar
• Moore‐Ede M. C., Campbell S. S., Reiter R. J. Introduction. Electromagnetic fields and circadian rhythmicity, M. C. Moore‐Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 3–10
   Google Scholar
• Neff N. H., Barett R. E., Costa E. Selective depletion of caudate nucleus dopamine and serotonin during chronic manganese dioxide administration to squirrel monkeys. Experientia 1969; 25: 1140–1141
   PubMedGoogle Scholar
• Niles L. P., Wong Y. W., Mishra R. K., Brown G. M. Melatonin receptors in brain. European Journal of Pharmacology 1979; 55: 219–220
   PubMed Web of Science ®Google Scholar
• Olcese J., Reuss S., Semm P. Geomagnetic field detection in rodents. Life Sciences 1988; 42: 605–613
   PubMed Web of Science ®Google Scholar
• Oxenkrug G. F., McIntyre I. M., Gershon S. Effects of pinealectomy and aging on the serum corticosterone circadian rhythm in rats. Journal of Pineal Research 1984; 1: 181–185
   PubMed Web of Science ®Google Scholar
• Parkinson J. An essay on the shaking palsy. Sherwood, Neeley and Jones, London 1817
   Google Scholar
• Pazo J. H. Effects of melatonin on spontaneous and evoked neuronal activity in the mesencephalic reticular formation. Brain Research Bulletin 1979; 4: 725–730
   PubMed Web of Science ®Google Scholar
• Pick A. Ueber eine eigenthumliche Schreibstorung, Mikrographie, in Folge cerebraler Erkrankung. Prague Medizinische Wochenschrift 1903; 28: 1–4
   Google Scholar
• Reichardt L. F., Kelly R. B. A molecular description of nerve terminal function. Annual Review of Biochemistry 1983; 52: 871–926
   PubMed Web of Science ®Google Scholar
• Riklan M., Zahn T. P., Diller L. Human figure drawings before and after chemosurgery of the basal ganglia in Parkinsonism. Journal of Nervous and Mental Disease 1962; 135: 500–506
   PubMed Web of Science ®Google Scholar
• Rosen A. D., Lubowsky J. Magnetic fields influence on central nervous system function. Experimental Neurology 1987; 95: 679–687
   PubMed Web of Science ®Google Scholar
• Rozencwaig R., Grad B. R., Ochoa J. The role of melatonin and serotonin in aging. Medical Hypotheses 1987; 23: 337–352
   PubMed Web of Science ®Google Scholar
• Rusovan A., Kanje M. D600, a Ca2+ antagonist, prevents stimulation of nerve regeneration by magnetic fields. NeuroReport 1992; 3: 813–814
   PubMed Web of Science ®Google Scholar
• Sallanon M., Claustrat B., Touret M. Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. Acta Endocrinologica 1982; 101: 161–165
   PubMedGoogle Scholar
• Sandyk R. Weak magnetic fields as a novel therapeutic modality in Parkinson's disease. International Journal of Neuroscience 1992a; 66: 1–15
   PubMed Web of Science ®Google Scholar
• Sandyk R. Magnetic fields in the therapy of parkinsonism. International Journal of Neuroscience 1992b; 66: 209–235
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields in the treatment of Parkinson's disease with the “on‐off phenomenon”. International Journal of Neuroscience 1992c; 66: 97–106, Sandyk, R. (1993). The effects of picotesla range magnetic fields on perceptual organization and visual memory in parkinsonism. International Journal of Neuroscience, 73, 207–219
   PubMed Web of Science ®Google Scholar
• Sandyk R. Treatment of Parkinson's disease with magnetic fields reduces the requirement for antiparkinsonian medications. International Journal of Neuroscience 1994a; 74: 191–201
   PubMedGoogle Scholar
• Sandyk R. Reversal of a visuoconstructional deficit in Parkinson's disease by application of external magnetic fields: A report of five cases. International Journal of Neuroscience 1994b; 75: 213–228
   PubMed Web of Science ®Google Scholar
• Sandyk R. Improvement in word fluency performance in Parkinson's disease by administration of electromagnetic fields. International Journal of Neuroscience 1994c; 77: 23–46
   PubMedGoogle Scholar
• Sandyk R. A drug naive Parkinsonian patient successfully treated with weak electromagnetic fields. International Journal of Neuroscience
   Google Scholar
• Sandyk R., Fisher H. Serotonin in movement disorders. International Journal of Neuroscience 1988; 42: 185–205
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. L‐tryptophan supplementation in Parkinson's disease. International Journal of Neuroscience 1989a; 45: 215–219
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Increased incidence of neuroleptic‐induced movement disorders in pinealectomized rats. International Journal of Neuroscience 1989b; 48: 303–308
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Further observations on the unique efficacy of picotesla magnetic Fields in Parkinson's disease. International Journal of Neuroscience 1993; 69: 167–183
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Reversal of visual neglect in Parkinson's disease by treatment with picotesla range magnetic fields. International Journal of Neuroscience 1993; 73: 93–107
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Reversal of micrographia in Parkinson's disease by application of picotesla range magnetic fields. International Journal of Neuroscience 1994; 77: 77–84
   PubMedGoogle Scholar
• Sandyk R., Anninos P. A., Tsagas N., Derpapas K. Magnetic fields in the treatment of Parkinson's disease. International Journal of Neuroscience 1992; 63: 141–150
   PubMed Web of Science ®Google Scholar
• Sano I., Taniguchi K. L‐5‐hydroxytryptophan (L‐5‐HTP) Therapie des Morbus Parkinson. Munschen Medizinische Wochenschrifi 1972; 114: 1717–1719
   PubMedGoogle Scholar
• Scatton B., Javoy‐Agid F., Rouquier L., Dubois B., Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Research 1983; 275: 321–328
   PubMed Web of Science ®Google Scholar
• Scatton B., Dennis T., L'heureux R., Monfort J. C., Duyckaerts C., Javoy‐Agid F. Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients. Brain Research 1986; 380: 181–185
   PubMed Web of Science ®Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Siegfried J. Die parkinsonsche krankheit und thre behandlung. Springer Verlag, Wien 1968; 106
   Google Scholar
• Smythe G. A., Lazarus L. Growth hormone regulation by melatonin and serotonin. Nature 1973; 244: 230–231
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Growth hormone response to melatonin in man. Science 1974a; 184: 1373–1374
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Suppression of HGH secretion by melatonin and cyproheptadine. Journal of Clinical Investigations 1974b; 54: 116–121
   PubMed Web of Science ®Google Scholar
• Stankov B., Fraschini F., Reiter R. J. Melatonin binding sites in the central nervous system. Brain Research Reviews 1991; 16: 245–256
   PubMedGoogle Scholar
• Stutz A. M. Effects of weak magnetic fields on gerbil spontaneous activity. Annals New York Academy of Sciences 1971; 187: 312–323
   Google Scholar
• Taylor E. M. The appraisal of children with cerebral deficits. Harvard University Press, Cambridge, Mass 1959
   Google Scholar
• Vacas M. I., Cardinali D. P. Diurnal changes in melatonin binding sites of hamster and rat brains. Correlation with neuroendocrine responsiveness to melatonin. Neuroscience Letters 1979; 15: 259–263
   PubMed Web of Science ®Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artifical magnetic field on serotonin N‐acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wendel O. T., Waterbury L. D., Pearce L. A. Increase in monoamine concentrations in rat brain following melatonin administration. Experientia 1974; 30: 1167–1168
   PubMedGoogle Scholar
• Wever R. Einfluss Schwacher Elektro‐magnetischer Felder auf die Circadiane Periodik des Menschen. Naturwissenschaften 1968; 55: 29–32
   PubMed Web of Science ®Google Scholar
• Williams L. M., Morgan P. J., Hatings M. H., Lawson W., Davidson G., Howell H. E. Melatonin receptors sites in the Syrian hamster brain and pituitary. Localization and characterization using ‘125I’iodomelatonin. Journal of Neuroendocrinology 1989; 1: 315–320
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Chess E. K., Anderson L. E. 60‐Hz electric field effects on pineal melatonin rhythms: time course for onset and recovery. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Zisapel N., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus. Brain Research 1983; 272: 378–381
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition of dopamine release by melatonin: regional distribution in the rat brain. Brain Research 1982; 246: 161–163
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus in vitro: variations with sex and the estrous cycle. Neuroendocrinology 1983; 37: 41–47
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Circadian variations in the inhibition of dopamine release from adult and newborn rat hypothalamus by melatonin. Neuroendocrinology 1985; 40: 102–108
   PubMed Web of Science ®Google Scholar